FDA Import Refusal 799-3142994-8/21/2 — Windlas Healthcare Private Limited

Windlas Healthcare Private Limited — FEI 3005339091

The FDA refused shipment 799-3142994-8/21/2 from Windlas Healthcare Private Limited (India) on February 9, 2023. The refused product falls under Drugs and Biologics — METFORMIN (ANTI-DIABETIC). Cited charges: 118,27,75 This firm has 4 other import refusals on record.

Refusal Details

Date
February 9, 2023
Country
India
Product Category
Drugs and Biologics
Product Code
61PDY26 METFORMIN (ANTI-DIABETIC)
Charges
118,27,75